Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine

Abstract

PCV13 was well tolerated and immunogenic, with most infants developing antipolysaccharide antibody concentrations of > or =0.35 microg/mL, as well as OPA responses, to each of the 13 serotypes.